GSK To Push For Its Two-Drug Combination Treatment For HIV At Upcoming AIDS Conference.
June 21, 2018
Reuters (6/20, Hirschler) reports GlaxoSmithKline (GSK) will try to build support for its two-drug combination to treat HIV at an upcoming AIDS conference compared to Gilead Sciences’ “tried and tested triple approach.” The article points out that GSK is...